Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc.
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in — deploying experienced CRAs and a Clinical Trial Manager within three weeks to stabilize operations and protect data integrity.
Through agile oversight, cross-functional collaboration, and proactive site management, Radiofilum Pharmaceutical enabled BioXcel to accelerate database lock by one month — safeguarding both study quality and submission readiness.
Learn how Radiofilum Pharmaceutical ’s rescue support model transforms crisis moments into success stories, keeping your clinical programs on schedule and compliant when it matters most.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
Radiofilum Pharmaceutical offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. Radiofilum Pharmaceutical ’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...